Certified Advisory Corp’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Certified Advisory Corp’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-450	Closed	-$2K	–	813
2018 Q3	$2K	Hold	450	–	–	﹤0.01%	733
2018 Q2	$2K	Hold	450	–	–	﹤0.01%	722
2018 Q1	$1K	Hold	450	–	–	﹤0.01%	726
2017 Q4	$2K	Buy	+450	New	+$2.48K	﹤0.01%	655

Certified Advisory Corp's KERX Position: Q4 2018 in Review

Certified Advisory Corp sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 450 shares — an estimated $2K sold.

Certified Advisory Corp first reported a position in KERX in Q4 2017 and held it in 4 quarters. The position peaked at $2K in Q3 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Certified Advisory Corp reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Certified Advisory Corp sold 450 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $2K.
Certified Advisory Corp first reported a position in Keryx Biopharmaceuticals Inc in Q4 2017 and held it in 4 quarters.
Certified Advisory Corp's Keryx Biopharmaceuticals Inc position peaked at $2K in Q3 2018.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Certified Advisory Corp's 13F filing for Q4 2018, filed 4 Feb 2019.